Intelligyn develops artificial intelligence tools to enhance gynecological diagnostics at the point of care. Their core product analyzes ultrasound images in real-time to provide clinicians with instant risk predictions for ovarian tumors and management suggestions. This technology aims to close diagnostic gaps in women's health by improving early detection rates.
Funding
Funding not disclosed
Founders
Product
Problem
Ovarian tumors are often detected late, leading to poorer outcomes for patients. Current diagnostic methods may lack the accuracy needed for early detection, resulting in unnecessary surgeries and increased healthcare costs. Bridging the expertise gap in gynecological care is crucial for improving early detection rates and saving lives.
Solution
IntelligynAI is an AI-powered diagnostic support tool designed to analyze ultrasound images in real-time during gynecological scans. The system provides instant risk predictions for ovarian tumors and offers management suggestions to healthcare professionals. By leveraging artificial intelligence, IntelligynAI aims to enhance the precision of diagnoses, reduce the need for exploratory surgeries, and improve access to quality healthcare for women worldwide. The technology supports better and more timely diagnoses, ultimately leading to improved patient outcomes.
Target Audience
The primary audience includes healthcare professionals, such as gynecologists and radiologists, involved in gynecological ultrasound imaging and diagnosis.
Features
- Real-time analysis of ultrasound images during the scan
- AI-driven risk predictions for ovarian tumors
- Management suggestions provided instantly
- Educational tool designed for healthcare professionals working with gynecological ultrasound (coming soon)